81551 Onc prostate 3 genes
Pathology & Lab
Also known as: prostate mRNA panel, 3-gene prostate test, prostate risk stratification
Oncology prostate cancer molecular panel utilizing 3-gene assessment to predict aggressive behavior and therapeutic response.
Clinical Context
Identifies men with high-risk prostate cancer to guide treatment intensity and monitor for castration resistance. Used in newly diagnosed or recurrent disease.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.